9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes
Nonalcoholic fatty liver disease (NAFLD) is quickly becoming the most common liver disease worldwide. Within the NAFLD spectrum, patients with nonalcoholic steatohepatitis (NASH) are at the highest risk of developing cirrhosis and disease progression to hepatocellular carcinoma. To date, therapeutic...
Main Authors: | Adriana R. Schultz Moreira, Sabrina Rüschenbaum, Stefan Schefczyk, Ulrike Hendgen-Cotta, Tienush Rassaf, Ruth Broering, Matthias Hardtke-Wolenski, Laura Elisa Buitrago-Molina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8279 |
Similar Items
-
Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
by: Yan-Mei Wang, et al.
Published: (2022-01-01) -
High Glucose Concentration Impairs 5-PAHSA Activity by Inhibiting AMP-Activated Protein Kinase Activation and Promoting Nuclear Factor-Kappa-B-Mediated Inflammation
by: Yan-Mei Wang, et al.
Published: (2019-01-01) -
Extracellular vesicles released by steatotic hepatocytes alter adipocyte metabolism
by: J.E. Mleczko, et al.
Published: (2022-02-01) -
Investigation of the Therapeutic Potential of New Antidiabetic Compounds Using Islet-on-a-Chip Microfluidic Model
by: Patrycja Sokolowska, et al.
Published: (2022-05-01) -
SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In Vivo
by: Nina Derby, et al.
Published: (2024-02-01)